AAAAAA

   
Results: 1-10 |
Results: 10
Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
Authors: Indrova, M Bubenik, J Simova, J Bieblova, J Jandlova, T Smahel, M Vonka, V Glazman-Kusnierczyk, H Pajtasz-Piasecka, E Radzikowski, C Mikyskova, R
Citation: M. Indrova et al., Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A, ONCOL REP, 8(6), 2001, pp. 1371-1374
Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases
Authors: Mikyskova, R Bubenik, J Mendoza, L Vonka, V Smahel, M Simova, J Jandlova, T
Citation: R. Mikyskova et al., Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases, CLIN EXP M, 18(7), 2001, pp. 581-587
Intratumoral IL-2 gene transfer improves the therapeutic efficacy of IL-12but not IL-18
Authors: Sobota, V Bubenik, J Simova, J Jandlova, T
Citation: V. Sobota et al., Intratumoral IL-2 gene transfer improves the therapeutic efficacy of IL-12but not IL-18, FOL BIOL, 46(5), 2000, pp. 191-193
Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth
Authors: Mendoza, L Indrova, M Hajkova, R Reinis, M Smahel, M Vonka, V Bubenik, J Jandlova, T
Citation: L. Mendoza et al., Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth, FOL BIOL, 46(3), 2000, pp. 91-97
Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80, molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines
Authors: Simova, J Reinis, M Sobota, V Capkova, J Bubenik, J Jandlova, T
Citation: J. Simova et al., Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80, molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines, FOL BIOL, 46(1), 2000, pp. 11-15
CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice
Authors: Sobota, V Indrova, M Rossner, P Bubenik, J Jandlova, T
Citation: V. Sobota et al., CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice, ONCOL REP, 6(3), 1999, pp. 669-673
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16
Authors: Bubenik, J Simova, J Hajkova, R Sobota, V Jandlova, T Smahel, M Sobotkova, E Vonka, V
Citation: J. Bubenik et al., Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16, INT J ONCOL, 14(3), 1999, pp. 593-597
Interleukin 2 gene therapy of surgical minimal residual tumour disease: Characterization of cytolytic effector cells from tumour progressors and regressors
Authors: Hajkova, R Indrova, M Jandlova, T Bubenik, J Reinis, M
Citation: R. Hajkova et al., Interleukin 2 gene therapy of surgical minimal residual tumour disease: Characterization of cytolytic effector cells from tumour progressors and regressors, FOL BIOL, 45(6), 1999, pp. 227-231
Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines
Authors: Rossner, P Bubenik, J Sobota, V Indrova, M Hajkova, R Mendoza, L Jandlova, T Simova, J
Citation: P. Rossner et al., Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines, FOL BIOL, 45(5), 1999, pp. 173-177
IL-2 gene-modified tumour vaccines: Monitoring of IL-2 levels in serum andperitoneal cavity of vaccinated mice
Authors: Indrova, M Pajtasz-Piasecka, E Jandlova, T Simova, J Bubenik, J Radzikowski, C
Citation: M. Indrova et al., IL-2 gene-modified tumour vaccines: Monitoring of IL-2 levels in serum andperitoneal cavity of vaccinated mice, FOL BIOL, 45(1), 1999, pp. 7-11
Risultati: 1-10 |